The company — based in Lincoln, Nebraska and Pleasanton, California — said the money will fund regulatory and clinical programs supporting the eventual commercialization of its MIRA (miniaturized in vivo robotic assistant) surgical platform.
“Virtual Incision’s goal is to transform surgery by providing a practical and hassle-free platform that will enable efficient, effective and affordable access to robotic-assisted technology, regardless of the site of care,” CEO John Murphy said in a news release.
Endeavour Vision and Baird Capital led the round, with participation from returning investor Bluestem Capital and others..
The company recently announced the first surgery using MIRA: Dr. Michael A. Jobst at Bryan Medical Center in Lincoln conducted a robotically assisted right hemicolectomy procedure. The surgery was part of a clinical study allowed under Virtual Incision’s IDE from the FDA.